SCHEMBL26357499

SCHEMBL26357499

COC(CCl)CN(CCO)Cc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.49
▸ TSHR P16473 4/20 0.49
▸ MAPK1 P28482 2/20 0.47
▸ GAA P10253 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ POLB P06746 2/20 0.44
▸ HTT P42858 1/20 0.43
▸ ACHE P22303 2/20 0.43
▸ LMNA P02545 1/20 0.43
▸ HSD17B10 Q99714 2/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ KDM4E B2RXH2 2/20 0.40
▸ BCHE P06276 1/20 0.39
▸ SLC22A2 O15244 1/20 0.35
▸ SLC22A1 O15245 1/20 0.35
▸ SLC22A3 O75751 1/20 0.35
▸ ESR1 P03372 1/20 0.35
▸ CHRM2 P08172 1/20 0.35
▸ HTR1A P08908 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8321789 0.79 ALDH1A1 (0.58) ALDH1A1TSHRMAPK1GAAMAPT
SCHEMBL26253773 0.79 ALDH1A1 (0.58) ALDH1A1TSHRMAPK1GAAMAPT
SCHEMBL8543593 0.76 ALDH1A1 (0.46) ALDH1A1TSHRMAPK1GAAMAPT
SCHEMBL725217 0.75 ALDH1A1 (0.53) ALDH1A1TSHRMAPK1GAAMAPT
SCHEMBL3508595 0.75 ALDH1A1 (0.53) ALDH1A1TSHRMAPK1GAAMAPT
SCHEMBL17941715 0.75 ALDH1A1 (0.53) ALDH1A1TSHRMAPK1GAAMAPT
SCHEMBL8281045 0.75 TSHR (0.45) ALDH1A1TSHRMAPK1GAAMAPT
SCHEMBL17195397 0.74 HTT (0.56) ALDH1A1TSHRMAPK1GAAMAPT
SCHEMBL8171042 0.74 ALDH1A1 (0.49) ALDH1A1TSHRMAPK1GAAMAPT
SCHEMBL122771 0.74 HTT (0.68) ALDH1A1TSHRMAPK1GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023177845-A1 PROCESS OF MAKING DERIVATIVES OF SUBSTITUTED MORPHOLINES SUPERNUS PHARMACEUTICALS, INC. (US) 2023-09-21 — — WO disclosed
Send feedback